Creative Biolabs-Immuno-oncology

Anti-DNAJC9 (clone 35L0Z) SynExpress T7-mNe-I4-K Modified CD8+ T cells (CAT#: ITS-1224-CR2178)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DNAJC9 (clone 35L0Z). We employs the HBV (T7-mNeonGreen-IL-4-KpnI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Rabbit
Target
DNAJC9
Clone
35L0Z
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mNeonGreen
Promoter
T7
Effector Gene
IL-4
Insertion Sites
KpnI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
HBV
Transformation Accuracy
0.85
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.